Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Max Seidensticker

Has grant

Deputy Chairmen

Klinikum der Universität München

Germany

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Germany Professors in Medical Imaging Medical Imaging professors in Germany

Recent Grants

Grant: Close

"Post hoc analysis of the SIRFLOX study: radiomics analysis of baseline CT images with the intention to identify predictors of superior response and overall survival to a combined treatment approach (SIRT plus chemotherapy) as compared to chemotherapy alone" - The SIROMICS Study

Open Date: 2019-01-01

Close Date:

Grant: Close

"Changes in image-based resectability of primarily unresectable liver metastases from colorectal cancer following treatment with radioembolization (RE) + chemotherapy vs. chemotherapy alone [the REsect study]"

Open Date: 2016-01-01

Close Date: 2019-01-01

Grant: Close

"Transarterielle Chemoembolisation mit Sorafenib und Lipiodol (SORATACE) – präklinische Evaluierung anhand von VX-2 Tumoren der Leber im Kaninchenmodell“

Open Date: 2013-01-01

Close Date: 2014-01-01

Grant: Close

"Evaluation of Sorafenib in combination with local micro-therapy guided by Gd-EOB-DTPA enhanced MRI in patients with inoperable hepatocellular carcinoma“, SORAMIC trial, diagnostic study part

Open Date: 2009-01-01

Close Date:

Grant: Close

„Evaluation of the preventive effect of enoxaparin, pentoxifylline and ursodeoxycholic acid to radiation induced liver toxicity after brachytherapy of liver metastases from colorectal carcinoma, assessed in a prospective randomised trial“, ELDORADO trial

Open Date: 2009-01-01

Close Date: 2020-01-01

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (9)

Christian Stief

Chairman and Professor

Ludwig-Maximilians-Universität München Medizinische Fakultät

GERMANY

View details

Florian Dr. Reiter

GERMANY

View details

Olaf Dietrich

Ruprecht Karls Universität Heidelberg

GERMANY

View details

Najib Ben Khaled

GERMANY

View details

Mateusz Bilski

Deputy Head/MD

POLAND

View details

Bernhard Gebauer

Charité - Universitätsmedizin Berlin

GERMANY

View details

Łukasz Kuncman

assistant professor

Medical University of Lodz

POLAND

View details

Osman Öcal

Heidelberg University

GERMANY

View details

Jan Borggrefe

Ruhr-Universität Bochum

GERMANY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Max Seidensticker

Research Interests

Make your next move.

Explore related searches

Recent Grants

Articles (20)

Analgosedation in interventional radiology (Jun, 10.1055/a-2863-2198, 2026)

Bleomycin-Electrosclerotherapy in the treatment of superficial slow-flow vascular malformations of head and neck

Bone Mineral Density (BMD) Is Not a Prognostic Marker for Overall Survival in Advanced Hepatocellular Carcinoma Under Sorafenib or SIRT/Sorafenib Therapy: A Subanalysis of the SORAMIC Study

Comparative analysis of target volume coverage and liver exposure in high-dose-rate interstitial brachytherapy and<i> in</i><i> silico</i> MR LINAC-based stereotactic body radiotherapy plans for colorectal liver metastases

Detection rate and mutational landscape in extracranial arteriovenous malformations: a cohort study

Factors influencing diagnostic yield and complication risk in computed tomography fluoroscopy-guided lung biopsies: a 10-year single-center study

Histopathological outcomes of CT-guided high-dose-rate interstitial brachytherapy for HCC and predictive accuracy of the LI-RADS Radiation Treatment Response Algorithm v2024

Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR

Imaging in staging, treatment planning, and monitoring of hepatocellular carcinoma for local and locoregional therapies: consensus recommendations from EORTC and ESGAR (May 23, 10.1007/s00330-025-11699-7, 2025)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Pre- and Periprocedural Imaging Predicts Technical but not Clinical Success of Prostatic Artery Embolization Using Non-spherical PVA Particles-Insights From the Prospective PROEMBO Trial

Prognostic and predictive value of radiomics-based imaging features in patients with colorectal liver metastasis receiving radioembolisation in first-line setting

Quantitative ex vivo assessment of target temperature and ablation duration for protocol optimization of microwave ablation procedures with mr thermometry

Sequential or upfront triple combination with durvalumab, tremelimumab, and bevacizumab for patients with unresectable hepatocellular carcinoma: the MONTBLANC trial protocol (AIO-HEP-0325/ass)

Survival outcomes and toxicity profile after CT-guided HDR brachytherapy (interventional radiotherapy) for liver oligometastases in breast cancer patients: The BRALIBREST real world multicenter study

TCOF1 in extracellular vesicles predicts survival in patients with HCC treated with high-dose conformal radiotherapy

A minimally invasive animal model of atherosclerosis and neointimal hyperplasia for translational research

Comparison of Perioperative Outcomes for Prostate Artery Embolization Versus Transurethral Resection of the Prostate and Laser Enucleation for Benign Prostatic Hyperplasia: Results from the GRAND Study

Bleomycin Electrosclerotherapy (BEST) for Slow-Flow Malformations of the Upper Aerodigestive Tract

Atezolizumab plus bevacizumab before or after transarterial chemoembolization in hepatocellular carcinoma: Interim analysis of the DEMAND (AIO-HEP-0418) randomized phase II clinical trial

Collaborators (9)

Christian Stief

Florian Dr. Reiter

Olaf Dietrich

Najib Ben Khaled

Mateusz Bilski

Bernhard Gebauer

Łukasz Kuncman

Osman Öcal

Jan Borggrefe

Make your next move.